CLINICAL_TRIALS
withdrawal
· 2014-09-09
Clinical Trial Update: Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site [Phase 1]
Summary
A Phase 1 study to assess the safety and feasibility of using the CD Leycom Pressure/Conductance Catheter to determine the optimal left ventricular pacing site …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lancaster General Hospital | Conditions: Heart Failure | Phase 1 | Status: WITHDRAWN